期刊
CLINICAL SCIENCE
卷 116, 期 5-6, 页码 451-465出版社
PORTLAND PRESS LTD
DOI: 10.1042/CS20080502
关键词
cancer; inflammation; intracellular signalling; nuclear factor kappa B (NF-kappa B); Rel
资金
- Agency for Science Technology and Research (A Star), Singapore
The NF-kappa B (nuclear factor kappa B) family of transcription factors are involved in a myriad of activities, including the regulation of immune responses, maturation of immune cells, development of secondary lymphoid organs and osteoclastogenesis. Fine tuning by positive and negative regulators keeps the NF-kappa B signalling pathway in check. Microbial products and genetic alterations in NF-kappa B and other signalling pathway components can lead to deregulation of NF-kappa B signalling in several human diseases, including cancers and chronic inflammatory disorders. NF-kappa B-pathway-specific therapies are being actively investigated, and these hold promises as interventions of NF-kappa B-related ailments.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据